Workshop: Diagnosis and Management of Cannabis Use Disorder and Other Cannabis-Related Problems-Diagnosis and Management of Cannabis Use Disorder and Other Cannabis-Related Problems

Video Transcription

Video Summary

This video transcript features a discussion between three addiction psychiatrists on the diagnosis and management of cannabis use disorder and related problems. It explores the increasing use of cannabis in the country and the challenges associated with it, emphasizing the importance of non-judgmental engagement with patients and discussing both the benefits and risks of cannabis use. The purpose of the workshop is to equip clinicians with the skills to identify patient challenges and offer intervention and treatment options. The video covers various aspects of cannabis use, including different products and potential medicinal properties, as well as legal issues relating to federal and state regulations. The psychiatrists stress the need for evidence-based pharmacotherapy and behavioral interventions to address cannabis use disorder. They discuss several medications with potential for treating the disorder, including N-acetylcysteine, gabapentin, epidiolex, and cannabidiol. The lack of FDA-approved medications specifically for cannabis use disorder is acknowledged, but clinicians are encouraged to consider these options alongside other approaches. The video concludes by underscoring the importance of monitoring cannabis use and considering mutual help programs as part of comprehensive treatment plans. Key points covered in the video include the impact of cannabis use disorder on mental health, the lack of approved medications, the potential risks associated with cannabis use, and the necessity for further research and improved interventions. Overall, it emphasizes the complex nature of cannabis use disorder and the need for individualized, comprehensive approaches to address it.

Keywords

addiction psychiatrists

cannabis use disorder

management

diagnosis

challenges

intervention

treatment options

medicinal properties

legal issues

behavioral interventions

FDA-approved medications

monitoring cannabis use

comprehensive treatment plans

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events